
Peruse this treatment update for the most recent data on the management of metastatic colorectal cancer, including a review of continuous vs intermittent chemotherapy, and the integration of targeted agents into standard treatment practices.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Recount data on the use of chemotherapeutic agents, including fluoropyrimidines, alkylating agents, and topoisomerase inhibitors, for treatment of metastatic colorectal cancer
- Describe investigations of targeted therapies in combination with standard treatments for the management of advanced colorectal cancer
- Describe novel treatment strategies currently under investigation, including the use of intermittent chemotherapy and the combination of several active therapies, for the treatment of patients with advanced colorectal cancer